Tumor protein p63/microRNA network in epithelial cancer cells

Current Genomics

Volumn 14, Issue 7, 2013, Pages 441-452

  Ratovitski, Edward A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Autophagy; Cell cycle arrest; Cell metabolism; Chemoresistance; Epigenetics; microRNA; TP63

Indexed keywords

BECLIN 1; CARNITINE PALMITOYLTRANSFERASE I; CASPASE; CISPLATIN; CYCLIN DEPENDENT KINASE 6; CYCLOOXYGENASE 2; DNA METHYLTRANSFERASE 1; HISTONE DEMETHYLASE; MICRORNA; MICRORNA 22; MICRORNA 221; MICRORNA 222; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN C MYB; PROTEIN P63; PROTEIN TYROSINE PHOSPHATASE; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F3;

APOPTOSIS; ARTICLE; AUTOPHAGY; BIOINFORMATICS; CARCINOGENESIS; CARCINOMA; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; NONHUMAN; SENESCENCE; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 84889075240     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/13892029113146660011     Document Type: Article

References (145)

1. Tsai, H. C.; Baylin, S. B. Cancer epigenetics: linking basic biology to clinical medicine. Cell Res., 2011, 21, 502-517. doi: 10. 1038/cr. 2011. 24.
2. Iorio, M. V.; Piovan, C.; Croce, C. M. Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim. Biophys. Acta., 2010, 1799, 694-701. doi. org/10. 1016/j. bbagrm. 2010. 05. 005.
3. Wiklund, E. D.; Kjems, J.; Clark, S. J. Epigenetic architecture and miRNA: reciprocal regulators. Epigenomics., 2010, 2, 823-840. doi 10. 2217/epi. 10. 51.
4. Esteller, M. Non-coding RNAs in human disease. Nat. Rev. Genet., 2011, 12, 861-874. doi: 10. 1038/nrg3074.
5. Lovat, F.; Valeri, N.; Croce, C. M. MicroRNAs in the pathogenesis of cancer. Semin. Oncol., 2011, 38, 724-733. doi: 10. 1053/j. seminoncol. 2011. 08. 006.
6. Pratt, A. J.; MacRae, I. J. The RNA-induced silencing complex: a versatile gene-silencing machine. J. Biol. Chem., 2009, 284, 17897-17901. doi: 10. 1074/jbc. R900012200.
7. MacFarlane, L. A.; Murphy, P. R. MicroRNA: Biogenesis, Function and Role in Cancer. Curr. Genomics, 2010, 11, 537-561. doi: 10. 2174/138920210793175895.
8. Pasquinelli, A. E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet., 2012, 13, 271-282. doi: 10. 1038/nrg3162.
9. Guo, H.; Ingolia, N. T.; Weissman, J. S.; Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature., 2010, 466, 835-840. sdoi: 10. 1038/nature09267.
10. Pillai, R. S.; Bhattacharyya, S. N.; Filipowicz, W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol., 2007, 17, 118-126. doi: 10. 1016/j. tcb. 2006. 12. 007.
11. Lim, L. P.; Lau, N. C.; Garrett-Engele, P.; Grimson, A.; Schelter, J. M.; Castle. J.; Bartel, D. P.; Linsley, P. S.; Johnson, J. M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature., 2005, 433, 769-773. doi: 10. 1038/nature 03315.
12. Calin, G. A.; Croce, C. M. MicroRNA signatures in human cancers. Nat. Rev. Cancer., 2006, 6, 857-866. doi: 10. 1038/nrc1997.
13. Lu, J.; Getz, G.; Miska, E. A.; Alvarez-Saavedra, E.; Lamb, J.; Peck, D.; Sweet-Cordero, A.; Ebert, B. L.; Mak, R. H.; Ferrando, A. A.; Downing, J. R.; Jacks, T.; Horvitz, H. R.; Golub, T. R. MicroRNA expression profiles classify human cancers. Nature., 2005, 435, 834-838. doi: 10. 1038/nature03702.
14. Volinia, S.; Calin, G. A.; Liu, C. G.; Ambs, S.; Cimmino, A.; Petrocca, F.; Visone, R.; Iorio, M.; Roldo, C.; Ferracin, M.; Prueitt, R. L.; Yanaihara, N.; Lanza, G.; Scarpa, A.; Vecchione, A.; Negrini, M.; Harris, C. C.; Croce, C. M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 2257-2261. 15 doi: 10. 1073/pnas. 0510 565103.
15. Krutovskikh, V. A.; Herceg, Z. Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. Bioessays., 2010, 32, 894-904. DOI: 10. 1002/bies. 201000040.
16. Miska, E. A. How microRNAs control cell division, differentiation and death. Curr. Opin. Genet. Dev., 2005, 15, 563-568. doi. org/10. 1016/j. gde. 2005. 08. 005.
17. Lee, Y. S.; Kim, H. K.; Chung, S.; Kim, K. S.; Dutta, A. Depletion of human miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J. Biol. Chem., 2005, 280, 16635-16641. doi: 10. 1074/jbc. M412247200.
18. Kumar, M. S.; Lu, J.; Mercer, K. L.; Golub, T. R.; Jacks, T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet., 2007, 39, 673-677. doi: 10. 1038/ng2003.
19. Xu, J.; Wang, Y.; Tan, X.; Jing, H. MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis. Autophagy, 2012, 8, 873-882. doi: 10. 4161/auto. 19629.
20. Kim, D. H.; Saetrom, P.; Snøve, O.; Rossi, J. J. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 16230-16235. doi: 10. 1073/pnas. 080 8830105.
21. Place, R. F.; Li, L. C.; Pookot, D.; Noonan, E. J.; Dahiya, R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 1608-1613. doi: 10. 1073/pnas. 0707594105.
22. Suzuki, K.; Kelleher, A. D. Transcriptional regulation by promoter targeted RNAs. Curr. Top. Med. Chem., 2009, 9, 1079-1087. DOI: 10. 2174/156802609789630875.
23. Younger, S. T.; Corey, D. R. Transcriptional regulation by miRNA mimics that target sequences downstream of gene termini. Mol. Biosyst., 2011, 7, 2383-2388. DOI: 10. 1039/C1MB05090G.
24. Chang, T. C.; Wentzel, E. A.; Kent, O. A.; Ramachandran, K.; Mullendore, M.; Lee, K. H.; Feldmann, G.; Yamakuchi, M.; Ferlito, M.; Lowenstein, C. J.; Arking, D. E.; Beer, M. A.; Maitra, A.; Mendell, J. T. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell, 2007, 26, 745-752. doi: 10. 1016/j. molcel. 2007. 05. 010.
25. Sylvestre, Y.; De Guire, V.; Querido, E.; Mukhopadhyay, U. K.; Bourdeau, V.; Major, F.; Ferbeyre, G.; Chartrand, P. An E2F/miR-20a autoregulatory feedback loop. J. Biol. Chem., 2007, 282, 2135-2143. doi: 10. 1074/jbc. M608939200.
26. He, L.; He, X.; Lim, L. P.; de Stanchina, E.; Xuan, Z.; Liang, Y.; Xue, W.; Zender, L.; Magnus, J.; Ridzon, D.; Jackson, A. L.; Linsley, P. S.; Chen, C.; Lowe, S. W.; Cleary, M. A.; Hannon, G. J. A microRNA component of the p53 tumour suppressor network. Nature, 2007, 447, 1130-1134. doi: 10. 1038/nature05939.
27. Iguchi, H.; Kosaka, N.; Ochiya T. Versatile applications of microRNA in anti-cancer drug discovery: from therapeutics to biomarkers. Curr. Drug Discov. Technol., 2010, 7, 95-105. 16doi. org/10. 2174/157016310793180648.
28. Galasso, M.; Elena Sana, M.; Volinia S. Non-coding RNAs: a key to future personalized molecular therapy? Genome Med., 2010, 2, 12. doi: 10. 1186/gm133.
29. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K. G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature., 2005, 438, 685-689. doi: 10. 1038/nature 04303.
30. Ebert, M. S.; Neilson, J. R.; Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods., 2007, 4, 721-726. doi: 10. 1038/nmeth1079.
31. Ory, B.; Ellisen, L. W. A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic op portunity. Oncotarget, 2011, 2, 259-264.
32. Yi, R.; Poy, M. N.; Stoffel, M.; Fuchs, E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature, 2008, 452, 225-229. DOI: http://dx. doi. org/10. 1038/nature06642.
33. Knouf, E. C.; Garg, K.; Arroyo, J. D.; Correa, Y.; Sarkar, D.; Parkin, R. K.; Wurz, K.; O'Briant, K. C.; Godwin, A. K.; Urban, N. D.; Ruzzo, W. L.; Gentleman, R.; Drescher, C. W.; Swisher, E. M.; Tewari, M. An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription. Nucleic Acids Res., 2012, 40, 499-510. DOI: http://dx. doi. org/10. 1093/nar/gkr731.
34. Melar-New, M.; Laimins, L. A. Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J. Virol., 2010, 84, 5212-5221. DOI: http://dx. doi. org/10. 1128/JVI. 00078-10.
35. Chikh, A.; Matin, R. N.; Senatore, V.; Hufbauer, M.; Lavery, D.; Raimondi, C.; Ostano, P.; Mello-Grand, M.; Ghimenti, C.; Bahta, A.; Khalaf, S.; Akgül, B.; Braun, K. M.; Chiorino, G.; Philpott, M. P.; Harwood, C. A.; Bergamaschi, D. iASPP/p63 autoregulatory feedback loop is required for the homeostasis of stratified epithelia. EMBO J., 2011, 30, 4261-4273. DOI: http://dx. doi. org/10. 1038/emboj. 2011. 302.
36. Tucci, P.; Agostini, M.; Grespi, F.; Markert, E. K.; Terrinoni, A.; Vousden, K. H.; Muller, P. A.; Dötsch, V.; Kehrloesser, S.; Sayan, B. S.; Giaccone, G.; Lowe, S. W.; Takahashi, N.; Vandenabeele, P.; Knight, R.; Levine, A. J.; Melino, G. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc. Natl. Acad. Sci. U. S. A., 2012, 109, 15312-15317. DOI: http://dx. doi. org/10. 1073/pnas. 11109 77109.
37. McKenna, D. J.; McDade, S. S.; Patel, D.; McCance, D. J. MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J. Virol., 2010, 84, 10644-10652. DOI: http://dx. doi. org/10. 1128/JVI. 00703-10.
38. Lena, A. M.; Shalom-Feuerstein, R.; Rivetti di Val Cervo, P.; Aberdam, D.; Knight, R. A.; Melino, G.; Candi, E. miR-203 represses 'stemness' by repressing DeltaNp63. Cell Death Differ., 2008, 15, 1187-1195. DOI: http://dx. doi. org/10. 1038/cdd. 2008. 69.
39. Liao, J. M.; Zhou, X.; Zhang, Y.; Lu, H. MiR-1246: a new link of the p53 family with cancer and Down syndrome. Cell Cycle, 2012, 11, 2624-2630. DOI: http://dx. doi. org/10. 4161/cc. 20809.
40. Neilsen, P. M.; Noll, J. E.; Mattiske, S.; Bracken, C. P.; Gregory, P. A.; Schulz, R. B.; Lim, S. P.; Kumar, R.; Suetani, R. J.; Goodall, G. J.; Callen, D. F. Mutant p53 drives invasion in breast tumors through up-regulation of miR-155. Oncogene, 2013, 32, 2992-3000. DOI: http://dx. doi. org/10. 1038/onc. 2012. 305.
41. Rivetti di Val Cervo, P.; Lena, A. M.; Nicoloso, M.; Rossi, S.; Mancini, M.; Zhou, H.; Saintigny, G.; Dellambra, E.; Odorisio, T.; Mahé, C.; Calin, G. A.; Candi, E.; Melino, G. p63-microRNA feedback in keratinocyte senescence. Proc. Natl. Acad. Sci. U. S. A., 2012, 109, 1133-1138. DOI: http://dx. doi. org/10. 1073/pnas. 1112257109.
42. Jackson, S. J.; Zhang, Z.; Feng, D.; Flagg, M.; O'Loughlin, E.; Wang, D.; Stokes, N.; Fuchs, E.; Yi, R. Rapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation. Development, 2013, 140, 1882-1891. DOI: http://dx. doi. org/10. 1242/dev. 089649.
43. Bailey, S. G.; Sanchez-Elsner, T.; Stephanou, A.; Cragg, M. S.; Townsend, P. A. Regulating the genome surveillance system: miRNAs and the p53 super family. Apoptosis, 2010, 15, 541-552. DOI: http://dx. doi. org/10. 1007/s10495-010-0456-1.
44. Wu, N.; Sulpice, E.; Obeid, P.; Benzina, S.; Kermarrec, F.; Combe, S.; Gidrol, X. The miR-17 family links p63 protein to MAPK signaling to promote the onset of human keratinocyte differentiation. PLoS One, 2012, 7, e45761. DOI: http://dx. doi. org/10. 1371/journal. pone. 0045761.
45. Tran, M. N.; Choi, W.; Wszolek, M. F.; Navai, N.; Lee, I. L.; Nitti, G.; Wen, S.; Flores, E. R.; Siefker-Radtke, A.; Czerniak, B.; Dinney, C.; Barton, M.; McConkey, D. J. The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J. Biol. Chem., 2013, 288, 3275-3288. DOI: http://dx. doi. org/10. 1074/jbc. M112. 408104.
46. Antonini, D.; Russo, M. T.; De Rosa, L.; Gorrese, M.; Del Vecchio, L.; Missero, C. Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells. J. Invest. Dermatol., 2010, 130, 1249-1257. DOI: http://dx. doi. org/10. 1038/jid. 2009. 438.
47. Bergholz, J.; Xiao, Z. X. Role of p63 in Development, Tumorigenesis and Cancer Progression. Cancer Microenviron., 2012, 5, 311-322. DOI: http://dx. doi. org/10. 1007/s12307-012-0116-9.
48. Huang, Y.; Sen, T.; Nagpal, J.; Upadhyay, S.; Trink, B.; Ratovitski, E.; Sidransky, D. ATM kinase is a master switch for the DeltaNp63alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage. Cell Cycle, 2008, 7, 2846-2855. doi. org/10. 4161/cc. 7. 18. 6627.
49. Huang, Y.; Chuang, A.; Hao, H.; Talbot, C.; Sen, T.; Trink, B.; Sidransky, D.; Ratovitski, E. Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells. Cell Death Differ., 2011, 18, 1220-1230. doi: 10. 1038/cdd. 2010. 188.
50. Huang, Y.; Chuang, A. Y.; Ratovitski, E. A. Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure. Cell Cycle, 2011, 10, 3938-3947. doi: 10. 4161/cc. 10. 22. 18107.
51. Huang, Y.; Guerrero-Preston, R.; Ratovitski, E. A. Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation. Cell Cycle, 2012, 11, 1247-1259. doi: 10. 4161/cc. 11. 6. 19670.
52. Huang, Y. P.; Kesselman, D.; Kizub, D.; Guerrero-Preston, R.; Ratovitski, E. A. Tumor protein p63/microRNA feedback regulation in squamous cell carcinomas upon cisplatin exposure. Cell Cycle, 2013, 12, 684-697. DOI: http://dx. doi. org/10. 4161/cc. 23598.
53. Ratovitski, E. A. Phospho-ΔNp63α-dependent microRNAs modulate chemoresistance of squamous cell carcinoma cells to cisplatin: At the crossroads of cell life and death. FEBS Lett., 2013, 587, 2536-2541. DOI: http://dx. doi. org/10. 1016/j. febslet. 2013. 06. 020.
54. Zheng, B.; Liang, L.; Wang, C.; Huang, S.; Cao, X.; Zha, R.; Liu, L.; Jia, D.; Tian, Q.; Wu, J.; Ye, Y.; Wang, Q.; Long, Z.; Zhou, Y.; Du, C.; He, X.; Shi, Y. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin. Cancer Res., 2011, 17, 7574-7583. DOI: http://dx. doi. org/10. 1158/1078-0432. CCR-11-1714.
55. Gonzalez, S.; Pisano, D. G.; Serrano, M. Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs. Cell Cycle, 2008, 7, 2601-2608. doi. org/10. 4161/cc. 7. 16. 6541.
56. Cho, H.; Orphanides, G.; Sun, X.; Yang, X.; Ogryzko, V.; Lees, E.; Nakatani, Y.; Reinberg, D. A human RNA polymerase II complex containing factors that modify chromatin structure. Mol. Cell. Biol., 1998, 18, 5355-5363. PMCID: PMC109120.
57. Zhang, Y.; Reinberg, D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes and Dev., 2001, 15, 2343-2360. doi: 10. 1101/gad. 927301.
58. Chen, K.; Rajewsky, N. The evolution of gene regulation by transcription factors and micro-RNAs. Nat. Rev. Genet., 2007, 8, 93-103. doi: 10. 1038/nrg1990.
59. Cloos, P. A.; Christensen, J.; Agger, K.; Helin, K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes and Dev., 2008, 22, 1115-1140. doi: 10. 1101/gad. 1652908.
60. Müller, J.; Verrijzer, P. Biochemical mechanisms of gene regulation by polycomb group protein complexes. Curr. Opin. Genet. Dev., 2009, 19, 150-158. doi. org/10. 1016/j. gde. 2009. 03. 001.
61. Zeng, X.; Chen, S.; Huang, H. Phosphorylation of EZH2 by CDK1 and CDK2: a possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions. Cell Cycle, 2011, 10, 579-583. doi. org/10. 4161/cc. 10. 4. 14722.
62. Ramsey, M. R.; He, L.; Forster, N.; Ory, B.; Ellisen, L. W. Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma. Cancer Res., 2011, 71, 4373-4379. doi: 10. 1158/0008-5472. CAN-11-0046.
63. Gallant-Behm, C. L.; Ramsey, M. R.; Bensard, C. L.; Nojek, I.; Tran, J.; Liu, M.; Ellisen, L. W.; Espinosa, J. M. ΔNp63α represses antiproliferative genes via H2A. Z deposition. Genes and Dev., 2012, 26, 2325-2236. DOI: http://dx. doi. org/10. 1101/gad. 198069. 112.
64. Hatziapostolou, M.; Iliopoulos, D. Epigenetic aberrations during oncogenesis. Cell. Mol. Life Sci., 2011, 68, 1681-702. Doi: 10. 1007/s00018-010-0624-z.
65. Berger, S. L. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev., 2002, 12, 142-148. doi. org/10. 1016/S0959-437X(02)00279-4.
66. Margueron, R.; Trojer, P.; Reinberg, D. The key to development: interpreting the histone code? Curr. Opin. Genet. Dev., 2005, 15, 163-176. doi. org/10. 1016/j. gde. 2005. 01. 005.
67. Nightingale, K. P.; O'Neill, L. P.; Turner, B. M. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr. Opin. Genet. Dev., 2006, 16, 125-136. doi. org/10. 1016/j. gde. 2006. 02. 015.
68. Guil, S.; Esteller, M. DNA methylomes, histone codes and miRNAs: tying it all together. Int. J. Biochem. Cell Biol., 2009, 41, 87-95. doi. org/10. 1016/j. biocel. 2008. 09. 005.
69. Dawson, M. A.; Kouzarides, T. Cancer epigenetics: from mechanism to therapy. Cell, 2012, 150, 12-27. doi. org/10. 1016/j. cell. 2012. 06. 013.
70. Sandoval, J.; Esteller, M. Cancer epigenomics: beyond genomics. Curr. Opin. Genet. Dev., 2012, 22, 50-55. doi. org/10. 1016/j. gde. 2012. 02. 008.
71. Lopez-Serra, P.; Esteller, M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene, 2012, 31, 1609-1622. doi: 10. 1038/onc. 2011. 354.
72. Roccaro, A. M.; Sacco, A.; Jia, X.; Azab, A. K.; Maiso, P.; Ngo, H. T.; Azab, F.; Runnels, J.; Quang, P.; Ghobrial, I. M. microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia. Blood, 2010, 116, 1506-1514. doi: 10. 1182/blood-2010-01-265686.
73. Lujambio, A.; Calin, G. A.; Villanueva, A.; Ropero, S.; Sánchez-Céspedes, M.; Blanco, D.; Montuenga, L. M.; Rossi, S.; Nicoloso, M. S.; Faller, W. J.; Gallagher, W. M.; Eccles, S. A.; Croce, C. M.; Esteller, M. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 13556-13561. doi: 10. 1073/pnas. 0803055105.
74. Fabbri, M.; Garzon, R.; Cimmino, A.; Liu, Z.; Zanesi, N.; Callegari, E.; Liu, S.; Alder, H.; Costinean, S.; Fernandez-Cymering, C.; Volinia, S.; Guler, G.; Morrison, C. D.; Chan, K. K.; Marcucci, G.; Calin, G. A.; Huebner, K.; Croce, C. M. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 15805-15810. doi: 10. 1073/pnas. 0707628104.
75. Garzon, R.; Liu, S.; Fabbri, M.; Liu, Z.; Heaphy, C. E.; Callegari, E.; Schwind, S.; Pang, J.; Yu, J.; Muthusamy, N.; Havelange, V.; Volinia, S.; Blum, W.; Rush, L. J.; Perrotti, D.; Andreeff, M.; Bloomfield, C. D.; Byrd, J. C.; Chan, K.; Wu, L. C.; Croce, C. M.; Marcucci, G. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood, 2009, 113, 6411-6418. doi. org/10. 1182/blood-2008-07-170589.
76. Duursma, A. M.; Kedde, M.; Schrier, M.; le Sage, C.; Agami, R. miR-148 targets human DNMT3b protein coding region. RNA, 2008, 14, 872-877. doi. org/10. 1261/rna. 972008.
77. Xu, Q.; Jiang, Y.; Yin, Y.; Li, Q.; He, J.; Jing, Y.; Qi, Y. T.; Xu, Q.; Li, W.; Lu, B.; Peiper, S. S.; Jiang, B. H.; Liu, L. Z. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. J. Mol. Cell Biol., 2013, 5, 3-13. doi: 10. 1093/jmcb/mjs049.
78. Takata, A.; Otsuka, M.; Yoshikawa, T.; Kishikawa, T.; Hikiba, Y.; Obi, S.; Goto, T.; Kang, Y. J.; Maeda, S.; Yoshida, H.; Omata, M.; Asahara, H.; Koike, K. MiRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity via directly targeting Dnmt1 expression. Hepatology, 2013, 57, 162-170. DOI: 10. 1002/hep. 26011.
79. Wang, Y. S.; Chou, W. W.; Chen, K. C.; Cheng, H. Y.; Lin, R. T.; Juo, S. H.; MicroRNA-152 mediates DNMT1-regulated DNA methylation in the estrogen receptor α gene. PLoS One, 2012, 7, e30635. DOI: 10. 1371/journal. pone. 0030635.
80. Varambally, S.; Cao, Q.; Mani, R. S.; Shankar, S.; Wang, X.; Ateeq, B.; Laxman, B.; Cao, X.; Jing, X.; Ramnarayanan, K.; Brenner, J. C.; Yu, J.; Kim, J. H.; Han, B.; Tan, P.; Kumar-Sinha, C.; Lonigro, R. J.; Palanisamy, N.; Maher, C. A.; Chinnaiyan, A. M. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science, 2008, 322, 1695-1699. DOI: 10. 1126/science. 1165395.
81. Zhang, J. G.; Guo, J. F.; Liu, D. L.; Liu, Q.; Wang, J. J. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. J. Thorac. Oncol., 2011, 6, 671-678. doi: 10. 1097/JTO. 0b013e318208 eb35.
82. Noonan, E. J.; Place, R. F.; Pookot, D.; Basak, S.; Whitson, J. M.; Hirata, H.; Giardina, C., Dahiya, R. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene, 2009, 28, 1714-1724. doi: 10. 1038/onc. 2009. 19.
83. Chen, B.; Li, H.; Zeng, X.; Yang, P.; Liu, X.; Zhao, X.; Liang, S. Roles of microRNA on cancer cell metabolism. J. Transl. Med., 2012, 10, 228. DOI: http://dx. doi. org/10. 1186/1479-5876-10-228.
84. Biggar, K. K.; Storey, K. B. The emerging roles of microRNAs in the molecular responses of metabolic rate depression. J. Mol. Cell Biol., 2011, 3, 167-175. DOI: http://dx. doi. org/10. 1093/jmcb/mjq045.
85. Tibiche, C.; Wang, E. MicroRNA regulatory patterns on the human metabolic network. Open Syst. Biol. J., 2008, 1, 1-8. DOI: http://dx. doi. org/10. 2174/1876392800801010001.
86. Godlewski, J.; Nowicki, M. O.; Bronisz, A.; Nuovo, G.; Palatini, J.; De Lay, M.; Van Brocklyn, J.; Ostrowski, M. C.; Chiocca, E. A.; Lawler, S. E. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol. Cell, 2010, 37, 620-632. DOI: http://dx. doi. org/10. 1016/j. molcel. 2010. 02. 018.
87. Dávalos, A.; Goedeke, L.; Smibert, P.; Ramírez, C. M.; Warrier, N. P.; Andreo, U.; Cirera-Salinas, D.; Rayner, K.; Suresh, U.; Pastor-Pareja, J. C.; Esplugues, E.; Fisher, E. A.; Penalva, L. O.; Moore, K. J.; Suárez, Y.; Lai, E. C.; Fernández-Hernando, C. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl. Acad. Sci. U. S. A., 2011, 108, 9232-9237. DOI: http://dx. doi. org/10. 1073/pnas. 1102281108.
88. Wilfred, B. R.; Wang, W. X.; Nelson, P. T. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol. Genet. Metab., 2007, 91, 209-217. DOI: http://dx. doi. org/10. 1016/j. ymgme. 2007. 03. 011.
89. Maddocks, O. D.; Vousden, K. H. Metabolic regulation by p53. J. Mol. Med. (Berl)., 2011, 89, 237-245. DOI: http://dx. doi. org/10. 1007/s00109-011-0735-5.
90. Kim, H. R.; Roe, J. S.; Lee, J. E.; Hwang, I. Y.; Cho, E. J.; Youn, H. D. A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH. Biochem. Biophys. Res. Commun., 2012, 418, 682-688. DOI: http://dx. doi. org/10. 1016/j. bbrc. 2012. 01. 077.
91. Kim, H. R.; Roe, J. S.; Lee, J. E.; Cho, E. J.; Youn, H. D. p53 regulates glucose metabolism by miR-34a. Biochem. Biophys. Res. Commun., 2013, 437, 225-231. DOI: http://dx. doi. org/10. 1016/j. bbrc. 2013. 06. 043.
92. Jeon, T. I.; Osborne, T. F. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol. Metab., 2012, 23, 65-72. DOI: http://dx. doi. org/10. 1016/j. tem. 2011. 10. 004.
93. He, X. P.; Shao, Y.; Li, X. L.; Xu, W.; Chen, G. S.; Sun, H. H.; Xu, H. C.; Xu, X.; Tang, D.; Zheng, X. F.; Xue, Y. P.; Huang, G. C.; Sun, W. H. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth. FEBS J., 2012, 279, 4201-4212. DOI: http://dx. doi. org/10. 1111/febs. 12013.
94. Li, X.; Chen, YT.; Josson, S.; Mukhopadhyay, N. K.; Kim, J.; Freeman, M. R.; Huang, W. C. MicroRNA-185 and 342 Inhibit Tumorigenicity and Induce Apoptosis through Blockade of the SREBP Metabolic Pathway in Prostate Cancer Cells. PloS One, 2013, 8, e70987. DOI: http://dx. doi. org/10. 1371/journal. pone. 0070987.
95. Huang, Y. P.; Bell, L. N.; Okamura, J.; Kim, M. S.; Mohney, R. P.; Guerrero-Preston, R.; Ratovitski, E. A. Phospho-GGNp63NN/SREBF1 interaction: Bridging Cell Metabolism and Cisplatin Resistance. Cell Cycle, 2012, 11, 3810-3827. DOI: http://dx. doi. org/10. 4161/cc. 22022.
96. Mangala, L. S.; Zuzel, V.; Schmandt, R.; Leshane, E. S.; Halder, J. B.; Armaiz-Pena, G. N.; Spannuth, W. A.; Tanaka, T.; Shahzad, M. M.; Lin, Y. G.; Nick, A. M.; Danes, C. G.; Lee, J. W.; Jennings, N. B.; Vivas-Mejia, P. E.; Wolf, J. K.; Coleman, R. L.; Siddik, Z. H.; Lopez-Berestein, G.; Lutsenko, S.; Sood, A. K. Therapeutic Targeting of ATP7B in Ovarian Carcinoma. Clin. Cancer Res., 2009, 15, 3770-3780. DOI: http://dx. doi. org/10. 1158/1078-0432. CCR-08-2306.
97. Sachdeva, M.; Wu, H.; Ru, P.; Hwang, L.; Trieu, V.; Mo, Y. Y. MicroRNA-101-mediated Akt activation and estrogen-independent growth. Oncogene, 2011, 30, 822-831. doi: 10. 1038/onc. 2010. 463.
98. Su, H.; Yang, J. R.; Xu, T.; Huang, J.; Xu, L.; Yuan, Y.; Zhuang, S. M. MicroRNA-101, downregulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res., 2009, 69, 1135-1142. doi. org/10. 1158/0008-5472. CAN-08-2886.
99. Canavese, M.; Santo, L.; Raje, N. Cyclin dependent kinases in cancer: potential for therapeutic intervention. Cancer Biol. Ther., 2012, 13, 451-457. doi. org/10. 4161/cbt. 19589.
100. Medema, R. H.; Macůrek, L. Checkpoint control and cancer. Oncogene, 2012, 31, 2601-2613. doi: 10. 1038/onc. 2011. 451.
101. Lizé, M.; Klimke, A.; Dobbelstein, M. MicroRNA-449 in cell fate determination. Cell Cycle, 2011, 10, 2874-2882. doi: 10. 4161/cc. 10. 17. 17181.
102. Kim, Y. K.; Yu, J.; Han, T. S.; Park, S. Y.; Namkoong, B.; Kim, D. H.; Hur, K.; Yoo, M. W.; Lee, H. J.; Yang, H. K.; Kim, V. N. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucl. Acid Res., 2009, 37, 1672-1681. doi: 10. 1093/nar/gkp002.
103. Wang, Y.; Blelloch, R. Cell cycle regulation by microRNAs in stem cells. Results Probl. Cell Differ., 2011, 53, 459-472. Doi: 10. 1007/978-3-642-19065-0β19.
104. Walensky L. BCL-2 in the crosshairs: tipping the balance of life and death. Cell Death Differ., 2006, 13, 1339-1350. doi: 10. 1038/sj. cdd. 4401992.
105. Youle, R. J.; Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol., 2008, 9, 47-59. doi: 10. 1038/nrm2308.
106. Kumar, S. Caspase function in programmed cell death. Cell Death Differ., 2007, 14, 32-43. doi: 10. 1038/sj. cdd. 4402060.
107. Melino, G.; Knight, R. MicroRNAs meet cell death. Cell Death Differ., 2010, 17, 189-190. doi: 10. 1038/cdd. 2009. 122.
108. Galluzzi, L.; Morselli, E.; Vitale, I.; Kepp, O.; Senovilla, L.; Criollo, A.; Servant, N.; Paccard, C.; Hupé, P.; Robert, T.; Ripoche, H.; Lazar, V.; Harel-Bellan, A.; Dessen, P.; Barillot, E.; Kroemer, G. MiR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death. Cancer Res., 2010, 70, 1793-1804. doi. org/10. 1158/0008-5472. CAN-09-3112.
109. Liu, S.; Zhang, P.; Chen, Z.; Liu, M.; Li, X.; Tang, H. MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells. FEBS Lett., 2013, 587, 2247-2253. DOI: http://dx. doi. org/10. 1016/j. febslet. 2013. 05. 054.
110. Song, T.; Zhang, X.; Zhang, L.; Dong, J.; Cai, W.; Gao, J.; Hong, B. miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2. J. Cancer Res. Clin. Oncol., 2013, 139, 1189-1198. DOI: http://dx. doi. org/10. 1007/s00432-013-1392-6.
111. Zang, Y. S.; Zhong, Y. F.; Fang, Z.; Li, B.; An, J. MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression. Cancer Gene. Ther., 2012, 19, 773-778. DOI: http://dx. doi. org/10. 1038/cgt. 2012. 60.
112. Xie, Y.; Tobin, L. A.; Camps, J.; Wangsa, D.; Yang, J.; Rao, M.; Witasp, E.; Awad, K. S.; Yoo, N.; Ried, T.; Kwong, K. F. MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells. Oncogene, 2013, 32, 2442-2451. DOI: http://dx. doi. org/10. 1038/onc. 2012. 258.
113. Cimmino, A.; Calin, G. A.; Fabbri, M.; Iorio, M. V.; Ferracin, M.; Shimizu, M.; Wojcik, S. E.; Aqeilan, R. I.; Zupo, S.; Dono, M.; Rassenti, L.; Alder, H.; Volinia, S.; Liu, C. G.; Kipps, T. J.; Negrini, M.; Croce, C. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 13944-13949. doi: 10. 1073/pnas. 0506654102.
114. Xu, J.; Liao, X.; Wong, C. Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. Int. J. Cancer, 2010, 126, 1029-1035. DOI: 10. 1002/ijc. 24823.
115. Qiu, T.; Zhou, L.; Wang, T.; Xu, J.; Wang, J.; Chen, W.; Zhou, X.; Huang, Z.; Zhu, W.; Shu, Y.; Liu, P. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2. Int. J. Mol. Med., 2013, 32, 593-598. doi: 10. 3892/ijmm. 2013. 1439.
116. Kwon, J. E.; Kim, B. Y.; Kwak, S. Y.; Bae, I. H.; Han, Y. H. Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1. Apoptosis, 2013, 18, 896-909. DOI: http://dx. doi. org/10. 1007/s10495-013-0841-7.
117. Ji, F.; Zhang, H.; Wang, Y.; Li, M.; Xu, W.; Kang, Y.; Wang, Z.; Wang, Z.; Cheng, P.; Tong, D.; Li, C.; Tang, H. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone, 2013, 56, 220-226. DOI: http://dx. doi. org/10. 1016/j. bone. 2013. 05. 020.
118. Gao, J.; Li, L.; Wu, M.; Liu, M.; Xie, X.; Guo, J.; Tang, H.; Xie, X. MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1. PLos One, 2013, 8, e65138. DOI: http://dx. doi. org/10. 1371/journal. pone. 0065138.
119. Verdoodt, B.; Neid, M.; Vogt, M.; Kuhn, V.; Liffers, S. T.; Palisaar, R. J.; Noldus, J.; Tannapfel, A.; Mirmohammadsadegh, A. MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer. Int. J. Oncol., 2013, 43, 307-314. DOI: 10. 3892/ijo. 2013. 1915.
120. Wang, F.; Liu, M.; Li, X.; Tang, H. MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett., 2013, 587, 488-495. DOI: http://dx. doi. org/10. 1016/j. febslet. 2013. 01. 016.
121. Chio, C. C.; Lin, J. W.; Cheng, H. A.; Chiu, W. T.; Wang, Y. H.; Wang, J. J.; Hsing, C. H.; Chen, R. M. MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cells. Arch. Toxicol., 2013, 87, 459-468. DOI: http://dx. doi. org/10. 1007/s00204-012-0965-5.
122. Gong, J.; Zhang, J. P.; Li, B.; Zeng, C.; You, K.; Chen, M. X.; Yuan, Y.; Zhuang, S. M. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. Oncogene, 2013, 32, 3071-3079. DOI: http://dx. doi. org/10. 1038/onc. 2012. 318.
123. Garofalo, M.; Jeon, Y. J.; Nuovo, G. J.; Middleton, J.; Secchiero, P.; Joshi, P.; Alder, H.; Nazaryan, N.; Di Leva, G.; Romano, G.; Crawford, M.; Nana-Sinkam, P.; Croce, C. M. MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAILInduced Apoptosis in Lung Cancer. Plos One, 2013, 8, e67581. DOI: http://dx. doi. org/10. 1371/journal. pone. 0067581.
124. Lu, T.; Shao, N.; Ji, C. Targeting microRNAs to modulate TRAILinduced apoptosis of cancer cells. Cancer Gene Ther., 2013, 20, 33-37. DOI: http://dx. doi. org/10. 1038/cgt. 2012. 81.
125. Patron, J. P.; Fendler, A.; Bild, M.; Jung, U.; Müller, H.; Arntzen, M. Ø.; Piso, C.; Stephan, C.; Thiede, B.; Mollenkopf, H. J.; Jung, K.; Kaufmann, S. H.; Schreiber, J. MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. PloS One, 2012, 7, e35345. DOI: http://dx. doi. org/10. 1371/journal. pone. 0035345.
126. Bertero, T.; Bourget-Ponzio, I.; Puissant, A.; Loubat, A.; Mari, B.; Meneguzzi, G.; Auberger, P.; Barbry, P.; Ponzio, G.; Rezzonico, R. Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties. Cell Cycle, 2013, 12, 2183-2193. DOI: http://dx. doi. org/10. 4161/cc. 25330.
127. Frankel, L. B.; Lund, A. H. MicroRNA regulation of autophagy. Carcinogenesis, 2012, 3, 2018-2025. doi: 10. 1093/carcin/bgs266.
128. Zhu. H.; Wu, H.; Liu, X.; Li, B.; Chen, Y.; Ren, X.; Liu, C. G.; Yang, J. M. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy, 2009, 5, 816-823. PMCID: PMC3669137.
129. Frankel, L. B.; Wen, J.; Lees, M.; Høyer-Hansen, M.; Farkas, T.; Krogh, A.; Jäättelä, M.; Lund, A. H. microRNA-101 is a potent inhibitor of autophagy. EMBO J., 2011, 30, 4628-4641. doi: 10. 1038/emboj. 2011. 331.
130. Mathew, R.; Karp, C. M.; Beaudoin, B.; Vuong, N.; Chen, G.; Chen, H. Y.; Bray, K.; Reddy, A.; Bhanot, G.; Gelinas, C.; Dipaola, R. S.; Karantza-Wadsworth, V.; White, E. Autophagy suppresses tumorigenesis through elimination of p62. Cell, 2009, 137, 1062-1075. doi. org/10. 1016/j. cell. 2009. 03. 048.
131. Korkmaz, G.; le Sage, C.; Tekirdag, K. A.; Agami, R.; Gozuacik, D. miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. Autophagy, 2012, 8, 165-176. doi. org/10. 4161/auto. 8. 2. 18351.
132. Fu, L. L.; Wen, X.; Bao, J. K.; Liu, B. MicroRNA-modulated autophagic signaling networks in cancer. Int. J. Biochem. Cell Biol., 2012, 44, 733-736. DOI: http://dx. doi. org/10. 1016/j. biocel. 2012. 02. 004.
133. Levine, B.; Kroemer, G. Autophagy in the pathogenesis of disease. Cell, 2008, 132, 27-42. doi. org/10. 1016/j. cell. 2007. 12. 018.
134. Kroemer, G.; Mariño, G.; Levine, B. Autophagy and the integrated stress response. Mol. Cell, 2010, 40, 280-293. doi. org/10. 1016/j. molcel. 2010. 09. 023.
135. Moscat, J.; Diaz-Meco, M. T. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell, 2009, 137, 1001-1004. doi. org/10. 1016/j. cell. 2009. 05. 023.
136. Jegga, A. G.; Schneider, L.; Ouyang, X.; Zhang, J. Systems biology of the autophagy-lysosomal pathway. Autophagy, 2011, 7, 477-489. doi: 10. 4161/auto. 7. 5. 14811.
137. Xu, Y.; An, Y.; Wang, Y.; Zhang, C.; Zhang, H.; Huang, C.; Jiang, H.; Wang, X.; Li, X. miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells. Oncol. Rep., 2013, 29, 2019-2024. doi: 10. 3892/or. 2013. 2338.
138. Frankel, L. B.; Wen, J.; Lees, M.; Høyer-Hansen, M.; Farkas, T.; Krogh, A.; Jäättelä, M.; Lund, A. H. microRNA-101 is a potent inhibitor of autophagy. EMBO J., 2011, 30, 4628-4641. DOI: http://dx. doi. org/10. 1038/emboj. 2011. 331.
139. Maiuri, M. C.; Le Toumelin, G.; Criollo, A.; Rain, J. C.; Gautier, F.; Juin, P.; Tasdemir, E.; Pierron, G.; Troulinaki, K.; Tavernarakis, N.; Hickman, J. A.; Geneste, O.; Kroemer, G. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J., 2007, 26, 2527-2539. doi: 10. 1038/sj. emboj. 7601689.
140. Germain, M.; Nguyen, A. P.; Le Grand, J. N.; Arbour, N.; Vanderluit, J. L.; Park, D. S., Opferman, J. T.; Slack, R. S. MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner. EMBO J., 2011, 30, 395-407. doi: 10. 1038/emboj. 2010. 327.
141. Luo, S.; Rubinsztein, D. C. Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-xL. Cell Death Differ., 2010, 17, 268-277. doi: 10. 1038/cdd. 2009. 121.
142. Yousefi, S.; Simon, H. U. Apoptosis regulation by autophagy gene 5. Crit. Rev. Oncol. Hematol., 2007, 63, 241-244. doi: 10. 1016/j. critrevonc. 2007. 06. 005.
143. Yousefi, S.; Perozzo, R.; Schmid, I.; Ziemiecki, A.; Schaffner, T.; Scapozza, L.; Brunner, T.; Simon, H. U. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat. Cell Biol., 2006, 8, 1124-1132. doi: 10. 1038/ncb1482.
144. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: the next generation. Cell, 2011, 144, 646-674. doi. org/10. 1016/j. cell. 2011. 02. 013.
145. Zhu, A.; Xia, J.; Zuo, J.; Jin, S.; Zhou, H.; Yao, L.; Huang, H.; Han, Z. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer. Med. Oncol., 2012, 29, 2701-2709. DOI: http://dx. doi. org/10. 1007/s12032-011-0134-3.